Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_assertion type Assertion NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_head.
- NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_assertion description "[In this study, we assessed the effect of single nucleotide polymorphisms in genes for interleukin 1 receptor antagonist (IL1RN), interleukin 4 (IL4), interleukin 6 (IL6), interleukin 10 (IL10), interferon (IFNG), tumor necrosis factor (TNF) and the cell surface receptors tumor necrosis factor receptor II (TNFRSFIB), vitamin D receptor (VDR) and estrogen receptor alpha (ESR1) in a homogeneous cohort of 228 HLA identical sibling transplants for chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_provenance.
- NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_assertion evidence source_evidence_literature NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_provenance.
- NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_assertion SIO_000772 20305143 NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_provenance.
- NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_assertion wasDerivedFrom befree-2016 NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_provenance.
- NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_assertion wasGeneratedBy ECO_0000203 NP801324.RAkJw49WWj50M7OOC5F-mZBoTPQX-uDWx7t1VuUaa2Ypg130_provenance.